Skip to main content
Clinical Trials/NCT03630848
NCT03630848CompletedNot Applicable

Protein Concentration and Human Embryo Development

Ibn Sina Hospital2 sites in 1 country1,536 target enrollmentStarted: August 14, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,536
Locations
2
Primary Endpoint
Ongoing pregnancy rate

Study Overview

Brief Summary

Protein Concentration in Human Embryo Culture Media remains assigned to the manufacturers with no clear evidence on which concentration is ideal.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Intracytoplasmic sperm injection cycles

Exclusion Criteria

  • Not provided

Arms & Interventions

5 mg/ml protein concentration in Embryo Culture Media

No Intervention

10 mg/ml protein concentration in Embryo Culture Media

Experimental

Intervention: Effect of Protein on Blastocyst Development (Other)

Outcomes

Primary Outcomes

Ongoing pregnancy rate

Time Frame: 12 weeks

Secondary Outcomes

  • Clinical pregnancy rate(7 weeks)
  • embryo development(two months)
  • Implantation rate(7 weeks)
  • Blastocyst Formation(two months)
  • Miscarriage rate(12 weeks)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Muhammad Fawzy

ivF Lab Director

Ibn Sina Hospital

Study Sites (2)

Loading locations...

Similar Trials